LGALS3 and B-cell chronic lymphocytic leukemia: In addition, CLL patients with unmutated IGHV genes display a higher percentage of Gal-3 positive B cells (Figure 6B) and Gal-3 mRNA expression in B cells (Figure 6C) than those with mutated IGHV genes (p < 0.05).